CTLA4 gene polymorphisms are associated with chronic bronchitis

European Respiratory Journal

Volumn 34, Issue 3, 2009, Pages 598-604

  Zhu, G ^a   Agusti, A ^c,d,e   Gulsvik, A ^f   Bakke, P ^f   Coxsone, H ^g   Lomas, D A ^h   Silverman, E K ^b   Pillai, S G ^a   Calverley, P M A ⁱ   Donner, C F ^j   Levy, R D ^g   Pare P D ^g   Make, B J ^k   Rennard, S I ^l   Vestbo, J ^m   Wouters, E F M ⁿ  

^a GLAXOSMITHKLINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d Fundacion Caubet Cimera   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF BERGEN   (Norway)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^j IRCCS   (Italy)

^k NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^l UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^m HVIDOVRE HOSPITAL   (Denmark)

ⁿ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease; Genetic association; Replication; Smoking; Tobacco

Indexed keywords

ALANINE; THREONINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; CTLA4 GENE; DYSPNEA; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; NORWAY; PATHOGENESIS; PEDIGREE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM; T LYMPHOCYTE ACTIVATION;

AGED; ANTIGENS, CD; BRONCHITIS, CHRONIC; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION STUDIES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAL CAPACITY;

EID: 70349145704     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00141808     Document Type: Article

References (43)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. (Pubitemid 32378468)
2. Hanrahan JP, Sherman CB, Bresnitz EA, et al. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861-865.
3. Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006; 367: 1216-1219.
4. Redline S, Tishler PV, Rosner B, et al. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 1989; 129: 827-836. (Pubitemid 19094260)
5. Webster PM, Lorimer EG, Man SF, et al. Pulmonary function in identical twins: comparison of nonsmokers and smokers. Am Rev Respir Dis 1979; 119: 223-228.
6. Kauffmann F, Tager IB, Munoz A, et al. Familial factors related to lung function in children aged 6-10 years. Results from the PAARC epidemiologic study. Am J Epidemiol 1989; 129: 1289-1299. (Pubitemid 19148469)
7. Lebowitz MD, Knudson RJ, Burrows B. Family aggregation of pulmonary function measurements. Am Rev Respir Dis 1984; 129: 8-11. (Pubitemid 14180311)
8. McCloskey SC, Patel BD, Hinchliffe SJ, et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001; 164: 1419-1424. (Pubitemid 33124020)
9. Silverman EK, Mosley JD, Palmer LJ, et al. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum Mol Genet 2002; 11: 623-632. (Pubitemid 34285133)
10. Silverman EK, Palmer LJ, Mosley JD, et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70: 1229-1239. (Pubitemid 34450572)
11. Palmer LJ, Celedón JC, Chapman HA, et al. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet 2003; 12: 1199-1210.
12. Malhotra A, Peiffer AP, Ryujin DT, et al. Further evidence for the role of genes on chromosome 2 and chromosome 5 in the inheritance of pulmonary function. Am J Respir Crit Care Med 2003; 168: 556-561. (Pubitemid 37088598)
13. Turato G, Zuin R, Saetta M. Pathogenesis and pathology of COPD. Respiration 2001; 68: 117-128.
14. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672-688. (Pubitemid 37258549)
15. Sun G, Stacey MA, Vittor E, et al. Cellular and molecular characteristics of inflammation in chronic bronchitis. Eur J Clin Invest 1998; 28: 364-372. (Pubitemid 28261219)
16. Gamble E, Burns W, Zhu J, et al. Variation of CD8+ T-lymphocytes around the bronchial internal perimeter in chronic bronchitis. Eur Respir J 2003; 22: 992-995. (Pubitemid 37540654)
17. Tivol EA, Borriello F, Schweitzer AN, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-547.
18. Ueda H, Howson JMM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511. (Pubitemid 36648570)
19. Mohrs M, Lacy DA, Locksley RM. Stat signals release activated naïve Th cells from an anergic checkpoint. J Immunol 2003; 170: 1870-1876. (Pubitemid 36197404)
20. Luhder F, Chambers C, Allison JP, et al. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc Natl Acad Sci USA 2000; 97: 12204-12209. (Pubitemid 30815163)
21. Howard TD, Postma DS, Hawkins GA, et al. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002; 110: 743-751.
22. Muntha-Kaas MC, Carlsen KH, Helms PJ, et al. CTLA-4 polymorphisms in allergy and asthma and the TH1/TH2 paradigm. J Allergy Clin Immunol 2004; 114: 280-287.
23. Zhu G, Warren L, Aponte J, et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 2007; 176: 167-173. (Pubitemid 47057853)
24. Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in COPD. Am J Respir Crit Care Med 2008; 178: 500-505.
25. Pillai SG, Zhu G, Gulsvik A, et al. SERPINE2 and COPD. Am J Respir Crit Care Med 2007; 176: 726.
26. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
27. Internation HapMap Project. www.hapmap.org Date last updated: April, 2: 2009.
28. Lange C, DeMeo D, Silverman EK, et al. PBAT: tools for family-based association studies. Am J Hum Genet 2004; 74: 367-369. (Pubitemid 38168624)
29. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
30. Horvath S, Xu X, Laird NM. The Family Based Association Test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-306. (Pubitemid 32366699)
31. Nyholt DR. A simple correction for multiple testing for single nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
32. Horvath S, Xu X, Lake SL, et al. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004; 26: 61-69. (Pubitemid 38036644)
33. Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
34. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55: 997-1004.
35. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229. (Pubitemid 34680308)
36. Agusti A, MacNee W, Donaldson K, et al. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 58: 832-834.
37. Di Stefano A, Caramori G, Capelli A, et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 78-85. (Pubitemid 39029072)
38. Cosio MG. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 3-5.
39. Anjos S, Nguyen A, Ounissi-Benkalha H, et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002; 277: 46478-46486. (Pubitemid 35417644)
40. Mäurer M, Loserth S, Kolb-Maurer A, et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002; 54: 1-8. (Pubitemid 34492947)
41. Sun T, Zhou Y, Yang M, et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 2008; 68: 7025-7034.
42. Tabor HK, Risch NJ, Myersv RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002; 3: 1-7.
43. Hattersley AT, McCarthy MI. A question of standards: what makes a good genetic association study? Lancet 2005; 366: 1315-1323.